Clinical Trial Update: Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the safety, tolerability, and feasibility of empagliflozin therapy in patients with dialysis-dependent end-stage kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetes Mellitus
• End-stage Kidney Disease

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University of Utah | Conditions: End-stage Kidney Disease, Kidney Disease, Chronic | Phase 1 | Status: COMPLETED